Trial
NCT00506662
Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Novo Nordisk A/S
Collaborators
—
Condition
Diabetes
Intervention
insulin detemir
Why stopped
See termination reason in detailed description
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-14